RT Journal Article
SR Electronic
T1 547 Reprogramming of type I interferon-responding tumor-reactive T lymphocytes associates with improved outcomes to neoadjuvant doublet immunotherapy in HNSCC
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A621
OP A621
DO 10.1136/jitc-2023-SITC2023.0547
VO 11
IS Suppl 1
A1 Li, Housaiyin
A1 Santos, Patricia
A1 Kulkarni, Aditi
A1 Isett, Brian
A1 Marion, Joy
A1 Chiosea, Simon
A1 Duvvuri, Uma
A1 Kim, Seungwon
A1 Kubik, Mark
A1 Zandberg, Dan P
A1 Bao, Riyue
A1 Vujanovic, Lazar
A1 Ferris, Robert
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A621.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.